Toshiki Sudo

1.4k total citations
30 papers, 1.1k citations indexed

About

Toshiki Sudo is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshiki Sudo has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshiki Sudo's work include Blood properties and coagulation (6 papers), Platelet Disorders and Treatments (6 papers) and S100 Proteins and Annexins (5 papers). Toshiki Sudo is often cited by papers focused on Blood properties and coagulation (6 papers), Platelet Disorders and Treatments (6 papers) and S100 Proteins and Annexins (5 papers). Toshiki Sudo collaborates with scholars based in Japan, United States and United Kingdom. Toshiki Sudo's co-authors include Yukio Kimura, Hiroyoshi Hidaka, Yukio Kimura, Ichiro Niki, Hideki Ito, Hideki Ito, Hideki Hayashi, Hisashi Hidaka, Hisayuki Yokokura and Masashi Kato and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Toshiki Sudo

27 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Toshiki Sudo 446 239 185 123 122 30 1.1k
Zsolt Karányi 552 1.2× 167 0.7× 169 0.9× 165 1.3× 23 0.2× 61 1.4k
Takanari Nakano 412 0.9× 118 0.5× 56 0.3× 116 0.9× 55 0.5× 57 1.1k
J Benvéniste 310 0.7× 99 0.4× 49 0.3× 263 2.1× 110 0.9× 45 1.0k
Anjana Sinha 250 0.6× 250 1.0× 52 0.3× 39 0.3× 83 0.7× 68 937
Yang Shi 556 1.2× 160 0.7× 97 0.5× 139 1.1× 42 0.3× 26 1.2k
Kiyoshi Kobayashi 343 0.8× 182 0.8× 41 0.2× 178 1.4× 44 0.4× 71 1.3k
Midori Masuda 575 1.3× 158 0.7× 33 0.2× 221 1.8× 151 1.2× 73 1.4k
Shinichiro Iida 581 1.3× 209 0.9× 50 0.3× 301 2.4× 33 0.3× 51 1.3k
Bing-Chang Chen 711 1.6× 64 0.3× 84 0.5× 311 2.5× 72 0.6× 44 1.5k
Kenneth Ndebele 425 1.0× 115 0.5× 50 0.3× 223 1.8× 24 0.2× 31 1.1k

Countries citing papers authored by Toshiki Sudo

Since Specialization
Citations

This map shows the geographic impact of Toshiki Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiki Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiki Sudo more than expected).

Fields of papers citing papers by Toshiki Sudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiki Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiki Sudo. The network helps show where Toshiki Sudo may publish in the future.

Co-authorship network of co-authors of Toshiki Sudo

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiki Sudo. A scholar is included among the top collaborators of Toshiki Sudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiki Sudo. Toshiki Sudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sims, Martin, et al.. (2025). The IAP antagonist tolinapant enhances the anti-tumor activity of cell therapies. European Journal of Pharmacology. 995. 177400–177400.
2.
Hadano, Yoshiro, et al.. (2023). Kluyvera intermedia bacteremia with septic shock: A case report. IDCases. 32. e01765–e01765. 5 indexed citations
3.
Hayashi, Hideki, Hiroyuki Kyushiki, Keisuke Nagano, et al.. (2011). Anopheline anti-platelet protein from a malaria vector mosquito has anti-thrombotic effects in vivo without compromising hemostasis. Thrombosis Research. 129(2). 169–175. 24 indexed citations
4.
Hayashi, Hideki & Toshiki Sudo. (2009). Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3β in platelets. Thrombosis and Haemostasis. 102(8). 327–335. 31 indexed citations
5.
Okamoto, Takashi, N Kanemoto, Takashi Ban, et al.. (2009). Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2. Archives of Biochemistry and Biophysics. 491(1-2). 46–52. 26 indexed citations
6.
Ohkura, Naoki, Katsutaka Oishi, Toshiki Sudo, et al.. (2008). CLOCK regulates circadian platelet activity. Thrombosis Research. 123(3). 523–527. 26 indexed citations
7.
Aihara, Ken‐ichi, Hiroyuki Azuma, Masashi Akaike, et al.. (2004). Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice. Journal of Biological Chemistry. 279(34). 35798–35802. 210 indexed citations
8.
Sudo, Toshiki. (2003). . Japanese Journal of Thrombosis and Hemostasis. 14(3). 265–269. 3 indexed citations
9.
Sudo, Toshiki, Hideki Ito, & Yukio Kimura. (2003). Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method. Platelets. 14(4). 239–246. 24 indexed citations
10.
Sudo, Toshiki, Hideki Ito, & Yukio Kimura. (2003). Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets. 14(6). 381–390. 79 indexed citations
11.
Ozeki, Yasushi, et al.. (2001). Characterization of Whole Blood Aggregation with a New Type of Aggregometer by a Screen Filtration Pressure Method. Thrombosis Research. 101(2). 65–72. 37 indexed citations
12.
Sudo, Toshiki, Hideki Ito, Yasushi Ozeki, & Yukio Kimura. (2001). Estimation of anti‐platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. British Journal of Pharmacology. 133(8). 1396–1404. 29 indexed citations
13.
Iino, Satoshi, Toshiki Sudo, Tae Niwa, et al.. (2000). Annexin XI may be involved in Ca2+‐ or GTP‐γS‐induced insulin secretion in the pancreatic β‐cell. FEBS Letters. 479(1-2). 46–50. 20 indexed citations
14.
15.
Inoué, Yoshihiro, et al.. (2000). Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model. British Journal of Pharmacology. 130(2). 231–241. 27 indexed citations
16.
Sudo, Toshiki, et al.. (2000). Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochemical Pharmacology. 59(4). 347–356. 138 indexed citations
17.
Sudo, Toshiki & Hiroyoshi Hidaka. (1998). Regulation of Calcyclin (S100A6) Binding by Alternative Splicing in the N-terminal Regulatory Domain of Annexin XI Isoforms. Journal of Biological Chemistry. 273(11). 6351–6357. 43 indexed citations
18.
Sudo, Toshiki, et al.. (1996). Isoform-Specific Intracellular Vesicle Formation by Recombinant Annexin XI-A in Sf9 Cells. Biochemical and Biophysical Research Communications. 223(3). 706–711. 6 indexed citations
19.
Niki, Ichiro, Hisayuki Yokokura, Toshiki Sudo, Masashi Kato, & Hisashi Hidaka. (1996). Ca2+ Signaling and Intracellular Ca2+ Binding Proteins. The Journal of Biochemistry. 120(4). 685–698. 109 indexed citations
20.
Sudo, Toshiki, Soichi TSUJI, Hideyuki Mannen, et al.. (1993). Application of DNA Fingerprinting to Investigation of Genetic Relationships between Laboratory Rabbit Strains. EXPERIMENTAL ANIMALS. 42(3). 337–342. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zsolt Karányi Breakdown of academic impact, for papers by Takanari Nakano Breakdown of academic impact, for papers by J Benvéniste Breakdown of academic impact, for papers by Anjana Sinha Breakdown of academic impact, for papers by Yang Shi Breakdown of academic impact, for papers by Kiyoshi Kobayashi Breakdown of academic impact, for papers by Midori Masuda Breakdown of academic impact, for papers by Shinichiro Iida Breakdown of academic impact, for papers by Bing-Chang Chen Breakdown of academic impact, for papers by Kenneth Ndebele
Rankless by CCL
2026